Twist and Ildong to develop antibodies for immuno-oncology applications
Under the deal, Twist will receive upfront, milestone and royalty payments as well as annual maintenance fees.
Immunology
Latest in
Immunology
Zura Bio signs merger deal with JATT Acquisition
The boards of directors of Zura Bio and JATT granted approval for the business combination.
Pierre Fabre and Lonza sign antibody manufacturing agreement
W0180 is presently being analysed in a Phase I clinical trial for various solid tumours.
Dupixent approval brings first biologic to youngest atopic dermatitis patients
Sanofi and Regeneron’s Dupixent, indicated to treat atopic dermatitis, is anticipated to reach sales of $5.3bn in the US by…
By
Unmet needs and opportunities for osteoarthritis
The global osteoarthritis space has a high level of unmet medical need, primarily due to the lack of disease-modifying drugs.
By
Regeneron to buy global license rights to Sanofi’s Libtayo
Regeneron will make an upfront payment of $900m to Sanofi as well as a 11% royalty on global net sales…
Osteoarthritis pipeline shifting from analgesics to disease-modifying treatments
Conventional analgesics prescribed for osteoarthritis offer inadequate pain relief and are associated with several adverse events.
By
Dragonfly and AbbVie partner to develop immune-mediated disease therapies
Leveraging the TriNKET platform of Dragonfly, the alliance will develop drug candidates for immune-mediated diseases.